Genetic therapy lowers joint bleeding in hemophilia B

COPENHAGEN – It’s early days yet, but results look highly promising for the ability of an experimental gene-transfer therapy to improve coagulation parameters in patients with severe hemophilia B....
Source: Hospitalist News - Category: Hospital Management Source Type: research